z-logo
open-access-imgOpen Access
Flutamide, Testolactone, and Reduced Hydrocortisone Dose Maintain Normal Growth Velocity and Bone Maturation Despite Elevated Androgen Levels in Children with Congenital Adrenal Hyperplasia
Author(s) -
Deborah P. Merke
Publication year - 2000
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.85.3.1114
Subject(s) - fludrocortisone , congenital adrenal hyperplasia , flutamide , medicine , endocrinology , hydrocortisone , dehydroepiandrosterone sulfate , antiandrogen , regimen , bone maturation , androgen , bone age , urology , hormone , prostate cancer , androgen receptor , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom